CMS Releases Revised Guidance for Historic Medicare Drug Price Negotiation Program
(Source – www.cms.gov/newsroom) For the first time in history, Medicare has the ability to directly negotiate the prices of covered
Read More
Part D/Prescription Drugs
Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients
(By Arthur Allen for KFF Health News) This week the FDA is expected to approve what many scientists and doctors
Read MorePatients Squeezed in Fight Over Who Gets to Bill for Pricey Infusion Drugs
(By Samantha Liss for KFF Health News) Health insurers and medical providers are battling over who should supply high-cost infusion
Read MoreOpioids are overrated for some common back pain, a study suggests
By Will Stone for NPR on June 28, 2023 Back and neck pain afflicts millions of American adults, driving many to
Read MoreThe DEA Relaxed Online Prescribing Rules During Covid. Now It Wants to Rein Them In.
(By Arielle Zionts for KFF Health News) Federal regulators want most patients to see a health care provider in person
Read MoreAn Alzheimer’s drug is on the way, but getting it may still be tough. Here’s why
(By Jon Hamilton for NPR) The first drug shown to slow down Alzheimer’s disease is likely to receive full approval
Read MoreCDC advisory panel recommends seniors ‘may’ get RSV vaccine
(By Helen Branswell for STAT) A panel of experts that advises the Centers for Disease Control and Prevention on vaccinations
Read MoreDrugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can’t Get Meds
(By Arthur Allen for KFF Health News) On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant
Read More‘I don’t know of a time that was worse’: What to know about cancer drug shortages
By Mariah Taylor on June 15, 2023 for Becker’s Hospital Review A survey found 93 percent and 70 percent of
Read MoreInflation Reduction Act Continues to Lower Out-of-Pocket Prescription Drug Costs for Drugs with Price Increases Above Inflation
(Source – cms.gov/newsroom) A continuing key priority of the Biden-Harris Administration is lowering prescription drug costs. Today, the Department of
Read More